TCMBANKGE005143 |
FCGR3B |
CD16; CD16A; CD16b; FCG3; FCGR3; FCGR3A; FCR-10; FCRIII; FCRIIIb |
Fc fragment of IgG receptor IIIb |
TCMBANKGE001111 |
KIT |
C-Kit; CD117; MASTC; PBT; SCFR |
KIT proto-oncogene, receptor tyrosine kinase |
TCMBANKGE009073 |
PTPRC |
B220; CD45; CD45R; GP180; L-CA; LCA; LY5; T200 |
protein tyrosine phosphatase receptor type C |
TCMBANKGE006572 |
GNLY |
D2S69E; LAG-2; LAG2; NKG5; TLA519 |
granulysin |
TCMBANKGE000029 |
GZMB |
C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT |
granzyme B |
TCMBANKGE000506 |
LAG3 |
CD223 |
lymphocyte activating 3 |
TCMBANKGE009014 |
MS4A1 |
B1; Bp35; CD20; CVID5; LEU-16; MS4A2; S7 |
membrane spanning 4-domains A1 |
TCMBANKGE013940 |
SOAT1 |
ACACT; ACAT; ACAT-1; ACAT1; SOAT; STAT |
sterol O-acyltransferase 1 |
TCMBANKGE013604 |
PLOD2 |
BRKS2; LH2; TLH |
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 |
TCMBANKGE011702 |
TNFRSF8 |
CD30; D1S166E; Ki-1 |
TNF receptor superfamily member 8 |
TCMBANKGE000205 |
NOS2 |
HEP-NOS; INOS; NOS; NOS2A |
nitric oxide synthase 2 |
TCMBANKGE010712 |
MME |
CALLA; CD10; CMT2T; NEP; SCA43; SFE |
membrane metalloendopeptidase |
TCMBANKGE000674 |
PDCD1 |
CD279; PD-1; PD1; SLEB2; hPD-1; hPD-l; hSLE1 |
programmed cell death 1 |
TCMBANKGE000477 |
EZH2 |
ENX-1; ENX1; EZH2b; KMT6; KMT6A; WVS; WVS2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
TCMBANKGE005400 |
ELF4 |
ELFR; MEF |
E74 like ETS transcription factor 4 |
TCMBANKGE002183 |
SLC22A2 |
2021/10/2 |
solute carrier family 22 member 2 |
TCMBANKGE013197 |
FCGR3A |
CD16; CD16A; FCG3; FCGR3; FCGRIII; FCR-10; FCRIII; FCRIIIA; IGFR3; IMD20 |
Fc fragment of IgG receptor IIIa |
TCMBANKGE010673 |
ASPG |
C14orf76; GPA/WT; LYSOLP |
asparaginase |
TCMBANKGE010044 |
CREBZF |
SMILE; ZF |
CREB/ATF bZIP transcription factor |
TCMBANKGE000262 |
TBC1D9 |
GRAMD9; MDR1 |
TBC1 domain family member 9 |
TCMBANKGE001161 |
IL2 |
IL-2; TCGF; lymphokine |
interleukin 2 |
TCMBANKGE000619 |
ASRGL1 |
ALP; ALP1; CRASH |
asparaginase and isoaspartyl peptidase 1 |
TCMBANKGE000898 |
MYC |
MRTL; MYCC; bHLHe39; c-Myc |
MYC proto-oncogene, bHLH transcription factor |
TCMBANKGE001178 |
STAT3 |
ADMIO; ADMIO1; APRF; HIES |
signal transducer and activator of transcription 3 |
TCMBANKGE009185 |
MEFV |
FMF; MEF; TRIM20 |
MEFV innate immuity regulator, pyrin |
TCMBANKGE003693 |
GZMH |
CCP-X; CGL-2; CSP-C; CTLA1; CTSGL2 |
granzyme H |
TCMBANKGE000652 |
STAT5B |
STAT5 |
signal transducer and activator of transcription 5B |
TCMBANKGE013111 |
KLRD1 |
CD94 |
killer cell lectin like receptor D1 |
TCMBANKGE006686 |
PRDM1 |
BLIMP1; PRDI-BF1 |
PR/SET domain 1 |
TCMBANKGE001160 |
CD274 |
B7-H; B7H1; PD-L1; PDCD1L1; PDCD1LG1; PDL1; hPD-L1 |
CD274 molecule |
TCMBANKGE007130 |
BCOR |
ANOP2; MAA2; MCOPS2 |
BCL6 corepressor |
TCMBANKGE001515 |
ADM |
AM; PAMP |
adrenomedullin |
TCMBANKGE000888 |
PLK2 |
SNK; hPlk2; hSNK |
polo like kinase 2 |
TCMBANKGE005322 |
TIA1 |
TIA-1; WDM |
TIA1 cytotoxic granule associated RNA binding protein |
TCMBANKGE000264 |
ABCB1 |
ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 |
ATP binding cassette subfamily B member 1 |
TCMBANKGE002913 |
ETS1 |
ETS-1; EWSR2; c-ets-1; p54 |
ETS proto-oncogene 1, transcription factor |
TCMBANKGE000276 |
NOS1 |
IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS |
nitric oxide synthase 1 |
TCMBANKGE012248 |
PDLIM7 |
LMP1; LMP3 |
PDZ and LIM domain 7 |
TCMBANKGE009459 |
TMTC3 |
LIS8; SMILE |
transmembrane O-mannosyltransferase targeting cadherins 3 |
TCMBANKGE008830 |
JAK3 |
JAK-3; JAK3_HUMAN; JAKL; L-JAK; LJAK |
Janus kinase 3 |
TCMBANKGE005378 |
KRT20 |
CD20; CK-20; CK20; K20; KRT21 |
keratin 20 |
TCMBANKGE002466 |
HAVCR2 |
CD366; HAVcr-2; KIM-3; SPTCL; TIM3; TIMD-3; TIMD3; Tim-3 |
hepatitis A virus cellular receptor 2 |
TCMBANKGE000736 |
TNFAIP3 |
A20; AISBL; OTUD7C; TNFA1P2 |
TNF alpha induced protein 3 |
TCMBANKGE000820 |
CFLAR |
CASH; CASP8AP1; CLARP; Casper; FLAME; FLAME-1; FLAME1; FLIP; I-FLICE; MRIT; c-FLIP; c-FLIPL; c-FLIPR; c-FLIPS; cFLIP |
CASP8 and FADD like apoptosis regulator |
TCMBANKGE000315 |
IL4 |
BCGF-1; BCGF1; BSF-1; BSF1; IL-4 |
interleukin 4 |